EPA Issues New Guidance on “Absence of an Ingredient” Claims

Last week, EPA issued a new Guidance on “Absence of an Ingredient” Claims Associated with Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)-Regulated Products which creates a pathway for adding certain “free from” claims to pesticide products. This guidance follows many discussions between EPA and industry on whether a “free from” claim is important information to [...]

Are your Multipacks, Kits, Co-packs, and Combos in Compliance?

The Kansas Department of Agriculture has recently started enforcing a state multipack policy based on interpretation of their pesticide law.  Moving forward, Kansas will require all new multipack configurations to be registered separately from the individual brand name registrations with the standard $150 fee per antimicrobial multipack ($180 fee per multipack for products not classified [...]

2023-10-12T13:26:52+00:00State|

Let’s Get Ready for MoCRA!

What is MoCRA? The Modernization of Cosmetics Regulation Act (MoCRA) of 2022 was signed into law by President Biden on December 29, 2022 as part of the 2023 Consolidated Appropriations Act , H.R. 2617. This Act significantly increases the U.S. Food & Drug Administration (FDA)’s oversight of cosmetic and personal care products from the 1938 [...]

California Legislation for Cosmetic Products

In addition to compliance assistance with the new Food & Drug Administration (FDA) Modernization of Cosmetics Regulation Act (MoCRA) of 2022, SRC offers compliance support for cosmetic ingredient disclosure and reporting requirements for the California Safe Cosmetics Act of 2005 (CSCA) (and the Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2020 (CFFIRKA) (Senate [...]

FDA Warning Letter Trends for Over-The-Counter Drugs

SRC monitors industry trends through frequent communication with regulating agencies, and review of warning letters and enforcement actions. From our monitoring of FDA Warning Letters, we have noticed some recent trends in FDA enforcement and interpretation of the regulations of over-the-counter drugs. Bob MacDonald, SRC’s VP of Regulatory Services provides a breakdown of these trends. [...]